Summary

KEY FINDINGS
The China ECG equipment market size is valued at $840.70 million as of 2026 and is expected to reach $1,621.11 million by 2034, progressing with a CAGR of 8.55% during the forecast years, 2026-2034.
MARKET INSIGHTS
China dominates the Asia-Pacific ECG equipment landscape through its vast population base, extensive hospital network, and government-driven healthcare modernization initiatives, transforming cardiac diagnostic infrastructure nationwide. The country's cardiovascular disease burden remains substantial, affecting hundreds of millions of citizens across urban and rural populations, creating sustained demand for diagnostic equipment.
Furthermore, China's Healthy China 2030 strategic plan prioritizes non-communicable disease prevention and management, channeling massive investments into healthcare facility construction and medical device procurement. The government actively supports domestic medical device manufacturing through favorable policies, subsidies, and preferential purchasing arrangements, strengthening local industry competitiveness.
Consequently, Chinese manufacturers like Mindray Medical International Limited have captured significant market share through cost-effective products meeting domestic quality standards while competing internationally. Additionally, the hierarchical medical system reform encourages primary care utilization, distributing ECG equipment across community health centers and township hospitals previously lacking diagnostic capabilities.
Digital health technology adoption accelerates throughout China's healthcare system, with hospitals implementing electronic medical records, telemedicine platforms, and AI-assisted diagnostic tools, enhancing ECG data utilization. Moreover, urbanization trends concentrate populations in cities, requiring expanded hospital capacity and sophisticated cardiac diagnostic equipment.
However, intense price competition characterizes China's market, pressuring profit margins for both domestic and international suppliers. Centralized government procurement policies through hospital group purchasing organizations negotiate aggressive pricing, limiting supplier flexibility. Nevertheless, the sheer scale of China's healthcare market creates enormous opportunities despite competitive challenges.
China's tiered healthcare delivery system encompasses primary care community health centers, secondary district hospitals, and tertiary provincial or national hospitals, forming the referral network. Tertiary hospitals in major cities like Beijing, Shanghai, Guangzhou, and Shenzhen maintain world-class facilities equipped with advanced ECG monitoring systems, computerized ECG machines, and comprehensive cardiac diagnostic capabilities.
These institutions drive demand for premium hospital-grade ECG equipment featuring sophisticated analysis algorithms, multi-channel recording, and seamless integration with hospital information systems. Meanwhile, secondary hospitals serving prefecture-level cities balance capability and cost considerations, typically procuring mid-range digital ECG systems offering reliable diagnostics without premium features.
Primary care facilities constitute the largest segment by facility count, requiring basic resting ECG devices and portable ECG monitors suitable for routine screening and initial assessments. Rural areas particularly benefit from government healthcare infrastructure investment, with newly constructed township hospitals acquiring essential diagnostic equipment, including entry-level ECG systems.
Additionally, private hospitals and specialty cardiac centers cater to affluent patients seeking premium healthcare services, investing in cutting-edge technology, including AI-assisted ECG interpretation systems and remote ECG monitoring solutions. The National Medical Products Administration oversees medical device regulation, requiring manufacturers to obtain registration certificates demonstrating safety, efficacy, and quality before market entry.
SEGMENTATION ANALYSIS
The China ECG equipment market is segmented into product type, technology, number of leads, portability, application, and end use industry. The number of leads segment is further categorized into 1 channel, 3 channels, 6 channels, and 12 channels.
Standard 12-lead ECG devices dominate China's electrocardiography equipment market, representing the clinical gold standard for comprehensive cardiac electrical activity assessment across healthcare facilities. These multi-channel systems simultaneously record heart signals from twelve different electrode positions, providing detailed spatial information about cardiac function essential for accurate diagnosis.
Consequently, 12-lead ECG equipment remains mandatory in hospital cardiology departments, emergency rooms, and intensive care units requiring thorough cardiac evaluations. The configuration enables clinicians to detect myocardial infarction, identify arrhythmia patterns, assess structural heart abnormalities, and monitor treatment effectiveness with proven diagnostic reliability.
Furthermore, China's medical practice guidelines and clinical protocols specify 12-lead ECG examinations as a standard procedure for patients presenting with chest pain, palpitations, or suspected cardiac conditions. National healthcare quality standards mandate that secondary and tertiary hospitals maintain 12-lead ECG diagnostic capabilities, driving consistent equipment deployment across thousands of facilities.
Additionally, the comprehensive data captured by 12-channel devices supports telemedicine consultations, allowing remote cardiologists to interpret ECGs transmitted from community hospitals lacking on-site specialists. Chinese medical education programs train physicians using 12-lead ECG interpretation, creating workforce familiarity and clinical preference for this established format.
Moreover, insurance reimbursement policies recognize 12-lead ECG examinations, ensuring healthcare providers receive payment for services rendered using standard equipment configurations. Domestic manufacturers prioritize 12-channel ECG production, achieving economies of scale that reduce costs while maintaining quality standards acceptable to Chinese healthcare institutions.
The devices integrate smoothly with hospital information technology systems prevalent throughout urban medical centers, enabling efficient data management and electronic health record documentation. Rural hospital modernization programs specifically procure 12-lead ECG systems, leapfrogging older analog technology to deploy current-generation digital platforms meeting national healthcare benchmarks.
COMPETITIVE INSIGHTS
Some of the top players operating in the China ECG equipment market include GE Healthcare, Philips Healthcare, Mindray Medical International Limited, Nihon Kohden Corporation, etc.
Mindray Medical International Limited stands as China's leading medical device manufacturer with a commanding presence throughout the domestic ECG equipment market and growing international operations. Headquartered in Shenzhen, the company specializes in patient monitoring systems, medical imaging equipment, and in-vitro diagnostic solutions serving hospitals, clinics, and healthcare institutions globally.
Mindray's comprehensive ECG product portfolio spans portable handheld devices, standard resting systems, stress testing equipment, Holter monitors, and sophisticated multi-parameter monitoring platforms suitable for diverse clinical applications. The BeneHeart series represents Mindray's flagship ECG line, combining advanced diagnostic capabilities with a competitive pricing positioning that appeals to cost-conscious Chinese healthcare providers.
These systems feature intuitive Chinese-language interfaces, workflow designs aligned with domestic clinical practices, and robust construction suitable for high-volume hospital environments. Furthermore, Mindray leverages extensive manufacturing scale advantages, operating production facilities throughout China that enable efficient supply chain management and rapid product delivery. The company maintains nationwide service networks providing installation support, user training, preventive maintenance, and spare parts availability, ensuring optimal equipment performance.
Additionally, Mindray's deep understanding of China's healthcare procurement processes, regulatory requirements, and hospital purchasing preferences gives the company strategic advantages over international competitors. Government policies favoring domestic medical device adoption benefit Mindray through preferential purchasing arrangements and regulatory support, accelerating product approvals.
COMPANY PROFILES
1. BIOTELEMETRY INC
2. GE HEALTHCARE
3. MCKESSON CORPORATION
4. MINDRAY MEDICAL INTERNATIONAL LIMITED
5. NIHON KOHDEN CORPORATION
6. PHILIPS HEALTHCARE
7. SCHILLER AG
8. SPACELABS HEALTHCARE
9. ZOLL MEDICAL CORPORATION
10. BAXTER

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & FORECAST
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. CHINA REPRESENTS ONE OF THE LARGEST ECG EQUIPMENT MARKETS GLOBALLY DUE TO ITS MASSIVE PATIENT BASE AND HOSPITAL NETWORK
2.5.2. DOMESTIC MANUFACTURERS HOLD A STRONG MARKET POSITION SUPPORTED BY LOCAL PRODUCTION AND COST ADVANTAGES
2.5.3. ADVANCED ECG SYSTEMS ARE WIDELY ADOPTED IN TERTIARY HOSPITALS AND URBAN HEALTHCARE FACILITIES
2.5.4. RURAL AND PRIMARY CARE MARKETS CONTINUE TO DRIVE VOLUME GROWTH FOR BASIC ECG DEVICES
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. HIGH AND GROWING PREVALENCE OF CARDIOVASCULAR DISEASES IS FUELING DEMAND FOR ECG DIAGNOSTICS
3.1.2. STRONG GOVERNMENT SUPPORT FOR DOMESTIC MEDICAL DEVICE MANUFACTURING IS ACCELERATING MARKET GROWTH
3.1.3. CONTINUOUS EXPANSION AND MODERNIZATION OF HOSPITAL INFRASTRUCTURE IS INCREASING EQUIPMENT UPGRADES
3.1.4. RAPID ADOPTION OF DIGITAL HEALTH TECHNOLOGIES IS ENHANCING ECG DATA UTILIZATION
3.2. KEY RESTRAINTS
3.2.1. INTENSE PRICE COMPETITION PUTS PRESSURE ON MARGINS FOR BOTH DOMESTIC AND INTERNATIONAL PLAYERS
3.2.2. CENTRALIZED PROCUREMENT POLICIES CAN LIMIT PRICING FLEXIBILITY FOR SUPPLIERS
3.2.3. REGULATORY COMPLIANCE REQUIREMENTS ADD TIME AND COST TO PRODUCT COMMERCIALIZATION
3.2.4. MARKET SATURATION IN MAJOR URBAN CENTERS SLOWS GROWTH FOR STANDARD ECG SYSTEMS
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.1.1. SHIFT TOWARD AI-ENABLED ECG ANALYSIS FOR EARLY DETECTION OF CARDIAC ABNORMALITIES
4.1.2. INCREASING USE OF ECG EQUIPMENT IN PRIMARY HEALTHCARE AND COMMUNITY CLINICS
4.1.3. STRONG GROWTH IN HOME-BASED AND REMOTE ECG MONITORING SOLUTIONS
4.1.4. RISING EXPORT ACTIVITY BY CHINESE ECG DEVICE MANUFACTURERS TO EMERGING MARKETS
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR CHINA
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
4.6. VALUE CHAIN ANALYSIS
4.6.1. RAW MATERIAL SUPPLIERS
4.6.2. ELECTRONIC COMPONENTS
4.6.3. DEVICE MANUFACTURING
4.6.4. SOFTWARE INTEGRATION
4.6.5. QUALITY TESTING
4.6.6. DISTRIBUTION CHANNELS
4.6.7. END-USER DELIVERY
4.7. KEY BUYING CRITERIA
4.7.1. DIAGNOSTIC ACCURACY
4.7.2. DEVICE PORTABILITY
4.7.3. REGULATORY APPROVAL
4.7.4. TOTAL COST OWNERSHIP
4.8. REGULATORY FRAMEWORK
5. ECG EQUIPMENT MARKET BY PRODUCT TYPE
5.1. RESTING ECG DEVICES
5.1.1. MARKET FORECAST FIGURE
5.1.2. SEGMENT ANALYSIS
5.2. STRESS ECG DEVICES
5.2.1. MARKET FORECAST FIGURE
5.2.2. SEGMENT ANALYSIS
5.3. HOLTER MONITORS
5.3.1. MARKET FORECAST FIGURE
5.3.2. SEGMENT ANALYSIS
5.4. ADVANCED ECG DEVICES
5.4.1. MARKET FORECAST FIGURE
5.4.2. SEGMENT ANALYSIS
5.5. OTHER PRODUCT TYPES
5.5.1. MARKET FORECAST FIGURE
5.5.2. SEGMENT ANALYSIS
6. ECG EQUIPMENT MARKET BY TECHNOLOGY
6.1. ANALOG
6.1.1. MARKET FORECAST FIGURE
6.1.2. SEGMENT ANALYSIS
6.2. DIGITAL
6.2.1. MARKET FORECAST FIGURE
6.2.2. SEGMENT ANALYSIS
7. ECG EQUIPMENT MARKET BY NUMBER OF LEADS
7.1. 1 CHANNEL
7.1.1. MARKET FORECAST FIGURE
7.1.2. SEGMENT ANALYSIS
7.2. 3 CHANNELS
7.2.1. MARKET FORECAST FIGURE
7.2.2. SEGMENT ANALYSIS
7.3. 6 CHANNELS
7.3.1. MARKET FORECAST FIGURE
7.3.2. SEGMENT ANALYSIS
7.4. 12 CHANNELS
7.4.1. MARKET FORECAST FIGURE
7.4.2. SEGMENT ANALYSIS
8. ECG EQUIPMENT MARKET BY PORTABILITY
8.1. STATIONARY
8.1.1. MARKET FORECAST FIGURE
8.1.2. SEGMENT ANALYSIS
8.2. PORTABLE
8.2.1. MARKET FORECAST FIGURE
8.2.2. SEGMENT ANALYSIS
9. ECG EQUIPMENT MARKET BY APPLICATION
9.1. CARDIOVASCULAR DISEASE DIAGNOSIS
9.1.1. MARKET FORECAST FIGURE
9.1.2. SEGMENT ANALYSIS
9.2. ARRHYTHMIA DETECTION
9.2.1. MARKET FORECAST FIGURE
9.2.2. SEGMENT ANALYSIS
9.3. OTHER APPLICATIONS
9.3.1. MARKET FORECAST FIGURE
9.3.2. SEGMENT ANALYSIS
10. ECG EQUIPMENT MARKET BY END USE INDUSTRY
10.1. HOSPITALS
10.1.1. MARKET FORECAST FIGURE
10.1.2. SEGMENT ANALYSIS
10.2. SPECIALTY CLINICS
10.2.1. MARKET FORECAST FIGURE
10.2.2. SEGMENT ANALYSIS
10.3. AMBULATORY SURGICAL CENTRES
10.3.1. MARKET FORECAST FIGURE
10.3.2. SEGMENT ANALYSIS
10.4. OTHER END USE INDUSTRIES
10.4.1. MARKET FORECAST FIGURE
10.4.2. SEGMENT ANALYSIS
11. COMPETITIVE LANDSCAPE
11.1. KEY STRATEGIC DEVELOPMENTS
11.1.1. MERGERS & ACQUISITIONS
11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
11.1.3. PARTNERSHIPS & AGREEMENTS
11.1.4. BUSINESS EXPANSIONS & DIVESTITURES
11.2. COMPANY PROFILES
11.2.1. BIOTELEMETRY INC
11.2.1.1. COMPANY OVERVIEW
11.2.1.2. PRODUCT LIST
11.2.1.3. STRENGTHS & CHALLENGES
11.2.2. GE HEALTHCARE
11.2.2.1. COMPANY OVERVIEW
11.2.2.2. PRODUCT LIST
11.2.2.3. STRENGTHS & CHALLENGES
11.2.3. MCKESSON CORPORATION
11.2.3.1. COMPANY OVERVIEW
11.2.3.2. PRODUCT LIST
11.2.3.3. STRENGTHS & CHALLENGES
11.2.4. MINDRAY MEDICAL INTERNATIONAL LIMITED
11.2.4.1. COMPANY OVERVIEW
11.2.4.2. PRODUCT LIST
11.2.4.3. STRENGTHS & CHALLENGES
11.2.5. NIHON KOHDEN CORPORATION
11.2.5.1. COMPANY OVERVIEW
11.2.5.2. PRODUCT LIST
11.2.5.3. STRENGTHS & CHALLENGES
11.2.6. PHILIPS HEALTHCARE
11.2.6.1. COMPANY OVERVIEW
11.2.6.2. PRODUCT LIST
11.2.6.3. STRENGTHS & CHALLENGES
11.2.7. SCHILLER AG
11.2.7.1. COMPANY OVERVIEW
11.2.7.2. PRODUCT LIST
11.2.7.3. STRENGTHS & CHALLENGES
11.2.8. SPACELABS HEALTHCARE (SUBSIDIARY OF OSI SYSTEMS INC)
11.2.8.1. COMPANY OVERVIEW
11.2.8.2. PRODUCT LIST
11.2.8.3. STRENGTHS & CHALLENGES
11.2.9. ZOLL MEDICAL CORPORATION (ACQUIRED BY ASAHI KASEI)
11.2.9.1. COMPANY OVERVIEW
11.2.9.2. PRODUCT LIST
11.2.9.3. STRENGTHS & CHALLENGES
11.2.10. BAXTER
11.2.10.1. COMPANY OVERVIEW
11.2.10.2. PRODUCT LIST
11.2.10.3. STRENGTHS & CHALLENGES









LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - ECG EQUIPMENT
TABLE 2: ECG EQUIPMENT MARKET REGULATORY FRAMEWORK
TABLE 3: MARKET BY PRODUCT TYPE, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 4: MARKET BY PRODUCT TYPE, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 5: MARKET BY TECHNOLOGY, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 6: MARKET BY TECHNOLOGY, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 7: MARKET BY NUMBER OF LEADS, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 8: MARKET BY NUMBER OF LEADS, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 9: MARKET BY PORTABILITY, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 10: MARKET BY PORTABILITY, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 11: MARKET BY APPLICATION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 12: MARKET BY APPLICATION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 13: MARKET BY END USE INDUSTRY, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 14: MARKET BY END USE INDUSTRY, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 15: KEY PLAYERS OPERATING IN THE CHINESE MARKET
TABLE 16: LIST OF MERGERS & ACQUISITIONS
TABLE 17: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 18: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 19: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR CHINA
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: SEGMENT GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2025
FIGURE 9: RESTING ECG DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 10: STRESS ECG DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 11: HOLTER MONITORS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 12: ADVANCED ECG DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 13: OTHER PRODUCT TYPES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 14: SEGMENT GROWTH POTENTIAL, BY TECHNOLOGY, IN 2025
FIGURE 15: ANALOG MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 16: DIGITAL MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 17: SEGMENT GROWTH POTENTIAL, BY NUMBER OF LEADS, IN 2025
FIGURE 18: 1 CHANNEL MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 19: 3 CHANNELS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 20: 6 CHANNELS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 21: 12 CHANNELS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 22: SEGMENT GROWTH POTENTIAL, BY PORTABILITY, IN 2025
FIGURE 23: STATIONARY MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 24: PORTABLE MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 25: SEGMENT GROWTH POTENTIAL, BY APPLICATION, IN 2025
FIGURE 26: CARDIOVASCULAR DISEASE DIAGNOSIS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 27: ARRHYTHMIA DETECTION MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 28: OTHER APPLICATIONS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 29: SEGMENT GROWTH POTENTIAL, BY END USE INDUSTRY, IN 2025
FIGURE 30: HOSPITALS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 31: SPECIALTY CLINICS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 32: AMBULATORY SURGICAL CENTRES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 33: OTHER END USE INDUSTRIES MARKET SIZE, 2026-2034 (IN $ MILLION)

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - ECG EQUIPMENT
TABLE 2: ECG EQUIPMENT MARKET REGULATORY FRAMEWORK
TABLE 3: MARKET BY PRODUCT TYPE, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 4: MARKET BY PRODUCT TYPE, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 5: MARKET BY TECHNOLOGY, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 6: MARKET BY TECHNOLOGY, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 7: MARKET BY NUMBER OF LEADS, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 8: MARKET BY NUMBER OF LEADS, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 9: MARKET BY PORTABILITY, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 10: MARKET BY PORTABILITY, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 11: MARKET BY APPLICATION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 12: MARKET BY APPLICATION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 13: MARKET BY END USE INDUSTRY, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 14: MARKET BY END USE INDUSTRY, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 15: KEY PLAYERS OPERATING IN THE CHINESE MARKET
TABLE 16: LIST OF MERGERS & ACQUISITIONS
TABLE 17: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 18: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 19: LIST OF BUSINESS EXPANSIONS & DIVESTITURES